title: Platinum resistance needs the mythbusters.
authors.forename: Britta
authors.initials: B
authors.lastname: Stordal
authors.forename: Ross
authors.initials: R
authors.lastname: Davey
mesh_terms: D000970:Antineoplastic Agents / Q000633:toxicity*; D017209:Apoptosis / Q000187:drug effects* / Q000502:physiology*; D045744:Cell Line, Tumor; D002945:Cisplatin / Q000633:toxicity; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D006657:Histones / Q000096:biosynthesis* / Q000235:genetics; D006801:Humans; D009363:Neoplasm Proteins / Q000096:biosynthesis* / Q000235:genetics; D009944:Organoplatinum Compounds / Q000633:toxicity*; D000077150:Oxaliplatin; D064249:Securin; D015398:Signal Transduction / Q000187:drug effects; D048051:p38 Mitogen-Activated Protein Kinases / Q000502:physiology*
chemical_list: D000970:Antineoplastic Agents; C468783:H2AX protein, human; D006657:Histones; D009363:Neoplasm Proteins; D009944:Organoplatinum Compounds; D064249:Securin; D000077150:Oxaliplatin; D048051:p38 Mitogen-Activated Protein Kinases; D002945:Cisplatin